Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Peregrine Awarded European Patent For Innovative Labeling Technology Featured In New Study In The Journal Of Nuclear Medicine
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it has been awarded a European patent for a novel device and methods for linking biological agents to labels for diagnostic and therapeutic applications. The technology, which is known as In-Line labeling, was developed for the production of radiolabeled anti-cancer antibodies, but is applicable to other agents as well. A study published today in the July 2009 issue of The Journal of Nuclear Medicine confirms that In-Line labeling can dramatically reduce the complexity and cost of producing radiolabeled cancer drugs(1). In-Line labeling is already being used for the production of Peregrine"s radiolabeled antibody Cotara(R), currently in Phase II trials for the treatment of glioblastoma multiforme, a deadly form of brain cancer.

Antiretrovirals Can Be Used To Prevent Spread Of HIV/AIDS, Model Shows
In addition to acting as life-saving therapy to people living with HIV/AIDS, WHO researchers say antiretrovirals (ARVs) may also be able to prevent the spread of HIV, Health-e/allAfrica.com reports. Reuben Granich, of the WHO, used a model to estimate the use of ARVs for the prevention of HIV transmission, and presented his findings to delegates gathered at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa (Thom, 7/20).
News of the day
Natural Orifice Translumenal Endoscopic Surgery® Research Benefits From Increased Grant From NOSCAR
The Natural Orifice Surgery Consortium for Assessment and Research® (NOSCAR®), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), has announced Olympus" continuing commitment to funding research in an emerging minimally invasive transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery®, with a $250,000 grant to the existing Olympus Research Fund supporting NOTES® research. This grant increases Olympus" total funding to $1.25 million.
Medical Devices

Funding, Restrictions Keep WFP From Reaching Millions Of Hungry North Koreans

The U.N."s World Food Programme (WFP) said Wednesday a "lack of international funding and new restrictions by North Korea on its staff and where it can operate has left it unable to reach millions of hungry women and children in the impoverished country," AP/Taiwan News reports. According to the WFP, it has received 15 percent of the $504 million it needs to feed 6.2 million North Koreans (Sanderson, 7/1). The agency has had to reduce its goal of reaching all 6.2 million, and is now targeting 2.27 million people, Torben Due, the WPF"s country representative in North Korea. "For adults, it doesn"t mean a lot if you live for a few months on a diet of cereals and vegetables, but for children, it is critical," Due said, adding that anecdotally there appears to be "an increase in the number of children being admitted to hospitals with severe malnutrition," via AFP/Google.com. He said the country"s chronic food shortages have created a negative cycle in which malnourished children grow up stunted with weak immune systems, and, in turn, give birth to less-than-healthy babies. According to SAPA/BusinessDay, the government told the WFP to "scale back its operations and get rid of its Korean-speaking staff, which reduced the number of workers to 16 last month from the 59 agreed upon last year" (7/1). According to Due, government leaders ordered the scale back without giving clear reasons why. "A long-running international standoff over North Korea"s nuclear programmes escalated on May 25 when Pyongyang carried out its second nuclear test, followed by further missile launches, which resulted in new U.N. sanctions," writes APF/Google.com. "We have not really received any contributions after the nuclear test was carried out," Due said (Martin, 7/1). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009